| scholarly article | Q13442814 |
| P50 | author | David Bernardo | Q38320584 |
| Luis I Fernández-Salazar | Q54222617 | ||
| José Antonio Garrote | Q54991000 | ||
| P2093 | author name string | Alberto J León | |
| Eduardo Arranz | |||
| Alfredo Blanco-Quirós | |||
| Benito Velayos | |||
| Asterio Barrera | |||
| Emma Gómez | |||
| Jose L Marcos | |||
| P2860 | cites work | Interleukin 18 maintains a long-standing inflammation in coeliac disease patients | Q79353317 |
| Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease | Q80410620 | ||
| Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice | Q80994922 | ||
| Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays | Q24814806 | ||
| Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease | Q34410491 | ||
| Cytokines in the pathogenesis of inflammatory bowel diseases | Q34546167 | ||
| Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease | Q34749376 | ||
| STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice | Q35769017 | ||
| Immunity, inflammation, and allergy in the gut. | Q36080132 | ||
| Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide | Q36376397 | ||
| The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications | Q36477912 | ||
| The pathogenic role of intestinal flora in IBD and colon cancer | Q37160701 | ||
| Bioactive IL-18 expression is up-regulated in Crohn's disease | Q41675600 | ||
| Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine | Q41824084 | ||
| Role of cytokines in inflammatory bowel disease | Q43065113 | ||
| Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. | Q48019542 | ||
| Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. | Q53649378 | ||
| Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis. | Q53655073 | ||
| Crohn's disease | Q54165583 | ||
| Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation | Q73405589 | ||
| Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease | Q73738632 | ||
| Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase | Q74250007 | ||
| Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease | Q78560229 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 580450 | |
| P577 | publication date | 2009-07-30 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD | |
| P478 | volume | 2009 |
| Q38631756 | Adenovirus type 5 rupture of lysosomes leads to cathepsin B-dependent mitochondrial stress and production of reactive oxygen species. |
| Q28597396 | Assessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis |
| Q38825374 | Assessment of disease activity in pediatric ulcerative colitis |
| Q57735524 | Association of the interleukin 15 (IL-15) gene polymorphisms with the risk of developing ulcerative colitis in Mexican individuals |
| Q45898977 | Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment. |
| Q38200060 | Blessing or curse? Proteomics in granzyme research |
| Q37948155 | Cells, cytokines and inflammatory bowel disease: a clinical perspective |
| Q24607561 | Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases |
| Q42255132 | Crohn's Disease and Ulcerative Colitis Show Unique Cytokine Profiles |
| Q41348755 | Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease |
| Q90151006 | Effect of Tripterygium wilfordii Polycoride on the NOXs-ROS-NLRP3 Inflammasome Signaling Pathway in Mice with Ulcerative Colitis |
| Q86531015 | Effects of modified Sanhuang decoction () enema on serum tumor necrosis factor-α and colonic mucosa interleukin-1β, interleukin-6 levels in ulcerative colitis rats |
| Q54271785 | Gene expression of tumor necrosis factor receptor associated-factor (TRAF)-1 and TRAF-2 in inflammatory bowel disease. |
| Q33788829 | IL-15: a central regulator of celiac disease immunopathology |
| Q84007918 | IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate |
| Q36125752 | Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease |
| Q51477530 | Impairment of Small Intestinal Function in Ulcerative Colitis: Role of Enteric Innervation. |
| Q38843204 | Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets |
| Q39371803 | Interferon-gamma signals via an ERK1/2-ARF6 pathway to promote bacterial internalization by gut epithelia. |
| Q37607910 | Interleukin 27: a double-edged sword for offense and defense |
| Q35309145 | Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis. |
| Q46487529 | Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis |
| Q46037099 | Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability. |
| Q38848936 | Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature |
| Q37413157 | Intestinal anti-inflammatory effects of RGD-functionalized silk fibroin nanoparticles in trinitrobenzenesulfonic acid-induced experimental colitis in rats |
| Q49624659 | Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapy |
| Q28080664 | Matrix metalloproteinases in inflammatory bowel disease: an update |
| Q38017870 | Metabolome and inflammasome in inflammatory bowel disease |
| Q41834962 | Modified Pulsatilla decoction attenuates oxazolone-induced colitis in mice through suppression of inflammation and epithelial barrier disruption |
| Q47817542 | Modulation of VIPergic phenotype of enteric neurons by colonic biopsy supernatants from patients with inflammatory bowel diseases: Involvement of IL-6 in Crohn's disease. |
| Q37762230 | Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? |
| Q57110341 | Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease |
| Q33728144 | Multivariate Modeling Identifies Neutrophil- and Th17-Related Factors as Differential Serum Biomarkers of Chronic Murine Colitis |
| Q35725419 | Pegylated arginine deiminase downregulates colitis in murine models |
| Q27693862 | Pulmonary-intestinal cross-talk in mucosal inflammatory disease |
| Q40362677 | Recombinant adeno-associated virus carrying thymosin β4 suppresses experimental colitis in mice |
| Q38060115 | Regulatory T cells in inflammatory bowel diseases and colorectal cancer |
| Q37992246 | Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing. |
| Q28298240 | Role of IL-15 in immune-mediated and infectious diseases |
| Q34274578 | Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats |
| Q57121540 | Spontaneous in vitro IL-6 production in various intestinal segments in patients with inflammatory bowel disease |
| Q38881849 | The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases |
| Q35651465 | Thrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis model |
| Q53821621 | Toll-like receptors-mediated pathways activate inflammatory responses in the esophageal mucosa of adult eosinophilic esophagitis. |
| Q39613832 | Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells |
| Q34084800 | Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis |
| Q35498214 | Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's disease |
Search more.